|
The 3rd annual European Antibody Congress is Europe’s definitive antibody event, bringing together thought leaders from across the industry. This lively and energetic meeting combines expert speakers, cutting-edge case studies, dedicated networking in an environment where discussion and debate thrives.
The 3rd annual European Antibody Congress focuses on issues in regulation and clinical trials, determining immunogenicity, successfully identifying lead candidates, advancing knowledge of production and manufacturing, developing next-generation antibody products and identifying the future therapeutic targets for antibody development. This is the leading platform to revolutionise future business strategy and capitalise on key opportunities in this sector. |
|
|
“Terrapinn’s annual European Antibody Congress is definitively a major event in the biopharmaceutical world. This meeting brings together representatives of big pharma, biotechs, start-up companies, CRO/CMOs, consultants, regulatory authorities and academics. All is done by the organisers to offer a great program with hot presentations, case studies and interactive panel sessions. Scientific and business networking opportunities are maximised in a casual atmosphere.”
Dr Alain Beck, Head of Physico-Chemistry Dept, Center of Immunology, Pierre Fabre
> Register your place today! > See the conference programme |